BioNxt Solutions Inc. (CSE:BNXT)
Canada · Delayed Price · Currency is CAD 0.3250
+0.0250 (8.33%)
Aug 10, 2026, 11:47 AM EST
BioNxt Solutions Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.01 | 0.06 | 0.03 | 0.36 | 0.14 | 1.35 |
Cash & Short-Term Investments | 0.01 | 0.06 | 0.03 | 0.36 | 0.14 | 1.35 |
Cash Growth | -96.33% | 70.82% | -91.10% | 167.01% | -89.93% | -47.70% |
Accounts Receivable | - | - | 0.06 | 0.28 | 0.46 | 0.55 |
Other Receivables | 0.03 | 0.08 | - | - | - | - |
Receivables | 0.03 | 0.08 | 0.06 | 0.28 | 0.46 | 0.55 |
Inventory | - | - | - | - | - | 0.74 |
Prepaid Expenses | 0.03 | 0.19 | 0.07 | 0.07 | 0.1 | 0.07 |
Total Current Assets | 0.07 | 0.32 | 0.16 | 0.72 | 0.69 | 2.7 |
Property, Plant & Equipment | 0.21 | 0.22 | 0.41 | 0.55 | 0.92 | 1.13 |
Goodwill | - | - | - | - | - | 4.87 |
Other Intangible Assets | 0 | 0 | 0 | 0 | 0 | 1.02 |
Other Long-Term Assets | 0.05 | 0.05 | - | - | - | - |
Total Assets | 0.33 | 0.59 | 0.57 | 1.27 | 1.61 | 9.73 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.68 | 0.71 | 1.11 | 0.6 | 0.46 | 0.52 |
Accrued Expenses | 0.59 | 3.19 | 2.97 | 0.9 | 0.91 | 1.8 |
Current Portion of Long-Term Debt | 5.24 | 1.96 | 2.73 | 4.89 | 0.61 | 2.98 |
Current Portion of Leases | - | - | - | - | 0.03 | 0.15 |
Other Current Liabilities | 0.08 | 0.11 | 0.06 | 0.15 | - | - |
Total Current Liabilities | 6.59 | 5.97 | 6.88 | 6.55 | 2.02 | 5.45 |
Long-Term Debt | 1.06 | 3.98 | 1.55 | - | 3.72 | 1.66 |
Long-Term Leases | - | - | - | - | - | 0.67 |
Long-Term Deferred Tax Liabilities | - | - | - | - | - | 0.28 |
Total Liabilities | 7.65 | 9.96 | 8.43 | 6.55 | 5.74 | 8.06 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 61.05 | 56.8 | 52.61 | 50.75 | 45.38 | 39.35 |
Retained Earnings | -75.61 | -71.37 | -64.69 | -59.93 | -55.55 | -43.38 |
Treasury Stock | - | - | - | - | - | -0.2 |
Comprehensive Income & Other | 7.25 | 5.2 | 4.22 | 3.9 | 6.04 | 5.9 |
Shareholders' Equity | -7.32 | -9.37 | -7.86 | -5.28 | -4.13 | 1.67 |
Total Liabilities & Equity | 0.33 | 0.59 | 0.57 | 1.27 | 1.61 | 9.73 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 6.3 | 5.95 | 4.28 | 4.89 | 4.37 | 5.46 |
Net Cash (Debt) | -6.29 | -5.89 | -4.25 | -4.53 | -4.23 | -4.1 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.05 | -0.05 | -0.04 | -0.05 | -0.05 | -0.06 |
Filing Date Shares Outstanding | 129.99 | 129.96 | 116.96 | 109.52 | 98.39 | 80.77 |
Total Common Shares Outstanding | 129.54 | 122.49 | 113.4 | 107.35 | 91.21 | 77.25 |
Working Capital | -6.51 | -5.65 | -6.71 | -5.83 | -1.33 | -2.75 |
Book Value Per Share | -0.06 | -0.08 | -0.07 | -0.05 | -0.05 | 0.02 |
Tangible Book Value | -7.32 | -9.37 | -7.86 | -5.28 | -4.13 | -4.22 |
Tangible Book Value Per Share | -0.06 | -0.08 | -0.07 | -0.05 | -0.05 | -0.05 |
Land | - | - | - | - | 0.35 | 0.35 |
Machinery | 0.51 | 0.59 | 0.96 | 1.29 | 1.07 | 1.06 |